_id
690f3960ccc777a4e85d18ce
Ticker
BTMD
Name
biote Corp
Exchange
NASDAQ
Address
1875 W. Walnut Hill Ln #100, Irving, TX, United States, 75038
Country
USA
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD
Website
https://www.biote.com
Description
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Last Close
2.85
Volume
124184
Current Price
2.7
Change
-5.263157894736839
Last Updated
2025-11-28T13:12:37.087Z
Image
-
Ipo Date
2021-04-28T00:00:00.000Z
Market Cap
127284472
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9143
Sentiment Sources
3
Rating
4.8333
Target Price
4.512
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
47956000
Cost Of Revenue
13538000
Gross Profit
34418000
Operating Expenses
26151000
Operating Income
8267000
Interest Expense
2733000
Pretax Income
8451000
Net Income
8188000
Eps
0.22305237587419954
Dividends Per Share
8000
Shares Outstanding
30680960
Income Tax Expense
-765000
EBITDA
12136000
Operating Margin
17.238718825590123
Total Other Income Expense Net
184000
Cash
28048000
Short Term Investments
-
Receivables
7972000
Inventories
16446000
Total Current Assets
57123000
Property Plant Equipment
12904000
Total Assets
111324000
Payables
4359000
Short Term Debt
6824000
Long Term Debt
97130000
Total Liabilities
176791000
Equity
-72751000
Depreciation
952000
Change In Working Capital
3120000
Cash From Operations
14072000
Capital Expenditures
690000
Cash From Investing
-690000
Cash From Financing
-4935000
Net Change In Cash
8447000
PE
3.3671
PB
-1.362372213440365
ROE
-11.254828112328353
ROA
7.355107613811937
FCF
13382000
Fcf Percent
0.2790474601718242
Piotroski FScore
3
Health Score
57
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
3.5
Economic Moat Investing Score
9.5
Garp Investing Score
5
Growth Investing Score
5
Momentum Investing Score
7.5
Net Net Investing Score
2
Quality Investing Score
5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
47956000
Quarters > 0 > income Statement > cost Of Revenue
13538000
Quarters > 0 > income Statement > gross Profit
34418000
Quarters > 0 > income Statement > operating Expenses
26151000
Quarters > 0 > income Statement > operating Income
8267000
Quarters > 0 > income Statement > interest Expense
2733000
Quarters > 0 > income Statement > pretax Income
8451000
Quarters > 0 > income Statement > net Income
8188000
Quarters > 0 > income Statement > eps
0.22305237587419954
Quarters > 0 > income Statement > dividends Per Share
8000
Quarters > 0 > income Statement > shares Outstanding
36708867
Quarters > 0 > income Statement > income Tax Expense
-765000
Quarters > 0 > income Statement > EBITDA
12136000
Quarters > 0 > income Statement > operating Margin
17.238718825590123
Quarters > 0 > income Statement > total Other Income Expense Net
184000
Quarters > 0 > balance Sheet > cash
28048000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
7972000
Quarters > 0 > balance Sheet > inventories
16446000
Quarters > 0 > balance Sheet > total Current Assets
57123000
Quarters > 0 > balance Sheet > property Plant Equipment
12904000
Quarters > 0 > balance Sheet > total Assets
111324000
Quarters > 0 > balance Sheet > payables
4359000
Quarters > 0 > balance Sheet > short Term Debt
6824000
Quarters > 0 > balance Sheet > long Term Debt
97130000
Quarters > 0 > balance Sheet > total Liabilities
176791000
Quarters > 0 > balance Sheet > equity
-72751000
Quarters > 0 > cash Flow > net Income
9216000
Quarters > 0 > cash Flow > depreciation
952000
Quarters > 0 > cash Flow > change In Working Capital
3120000
Quarters > 0 > cash Flow > cash From Operations
14072000
Quarters > 0 > cash Flow > capital Expenditures
690000
Quarters > 0 > cash Flow > cash From Investing
-690000
Quarters > 0 > cash Flow > cash From Financing
-4935000
Quarters > 0 > cash Flow > net Change In Cash
8447000
Quarters > 0 > ratios > PE
0.22305237587419954
Quarters > 0 > ratios > PB
-1.362372213440365
Quarters > 0 > ratios > ROE
-11.254828112328353
Quarters > 0 > ratios > ROA
7.355107613811937
Quarters > 0 > ratios > FCF
13382000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.2790474601718242
Quarters > 0 > health Score
57
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
48863000
Quarters > 1 > income Statement > cost Of Revenue
13875000
Quarters > 1 > income Statement > gross Profit
34988000
Quarters > 1 > income Statement > operating Expenses
24223000
Quarters > 1 > income Statement > operating Income
10765000
Quarters > 1 > income Statement > interest Expense
2852000
Quarters > 1 > income Statement > pretax Income
6075000
Quarters > 1 > income Statement > net Income
3185000
Quarters > 1 > income Statement > eps
0.08617657404150546
Quarters > 1 > income Statement > dividends Per Share
887000
Quarters > 1 > income Statement > shares Outstanding
36959000
Quarters > 1 > income Statement > income Tax Expense
2150000
Quarters > 1 > income Statement > EBITDA
9837000
Quarters > 1 > income Statement > operating Margin
22.03098458956675
Quarters > 1 > income Statement > total Other Income Expense Net
-4690000
Quarters > 1 > balance Sheet > cash
19601000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
9172000
Quarters > 1 > balance Sheet > inventories
12132000
Quarters > 1 > balance Sheet > total Current Assets
49504000
Quarters > 1 > balance Sheet > property Plant Equipment
12906000
Quarters > 1 > balance Sheet > total Assets
104798000
Quarters > 1 > balance Sheet > payables
3863000
Quarters > 1 > balance Sheet > short Term Debt
6807000
Quarters > 1 > balance Sheet > long Term Debt
98486000
Quarters > 1 > balance Sheet > total Liabilities
183638000
Quarters > 1 > balance Sheet > equity
-85104000
Quarters > 1 > cash Flow > net Income
3925000
Quarters > 1 > cash Flow > depreciation
910000
Quarters > 1 > cash Flow > change In Working Capital
-4648000
Quarters > 1 > cash Flow > cash From Operations
7086000
Quarters > 1 > cash Flow > capital Expenditures
1809000
Quarters > 1 > cash Flow > cash From Investing
-1962000
Quarters > 1 > cash Flow > cash From Financing
-27232000
Quarters > 1 > cash Flow > net Change In Cash
-22099000
Quarters > 1 > ratios > PE
0.08617657404150546
Quarters > 1 > ratios > PB
-1.1725571065989848
Quarters > 1 > ratios > ROE
-3.742479789434104
Quarters > 1 > ratios > ROA
3.0391801370255154
Quarters > 1 > ratios > FCF
5277000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.10799582506190779
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
48992000
Quarters > 2 > income Statement > cost Of Revenue
12610000
Quarters > 2 > income Statement > gross Profit
36382000
Quarters > 2 > income Statement > operating Expenses
26692000
Quarters > 2 > income Statement > operating Income
9690000
Quarters > 2 > income Statement > interest Expense
2905000
Quarters > 2 > income Statement > pretax Income
17455000
Quarters > 2 > income Statement > net Income
13718000
Quarters > 2 > income Statement > eps
0.3712283170513896
Quarters > 2 > income Statement > dividends Per Share
694000
Quarters > 2 > income Statement > shares Outstanding
36953000
Quarters > 2 > income Statement > income Tax Expense
1616000
Quarters > 2 > income Statement > EBITDA
21217000
Quarters > 2 > income Statement > operating Margin
19.778739386022206
Quarters > 2 > income Statement > total Other Income Expense Net
7765000
Quarters > 2 > balance Sheet > cash
41700000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
7765000
Quarters > 2 > balance Sheet > inventories
13451000
Quarters > 2 > balance Sheet > total Current Assets
68680000
Quarters > 2 > balance Sheet > property Plant Equipment
11502000
Quarters > 2 > balance Sheet > total Assets
123379000
Quarters > 2 > balance Sheet > payables
3335000
Quarters > 2 > balance Sheet > short Term Debt
6790000
Quarters > 2 > balance Sheet > long Term Debt
99847000
Quarters > 2 > balance Sheet > total Liabilities
208205000
Quarters > 2 > balance Sheet > equity
-89981000
Quarters > 2 > cash Flow > net Income
15839000
Quarters > 2 > cash Flow > depreciation
857000
Quarters > 2 > cash Flow > change In Working Capital
-4707000
Quarters > 2 > cash Flow > cash From Operations
6467000
Quarters > 2 > cash Flow > capital Expenditures
1630000
Quarters > 2 > cash Flow > cash From Investing
-1848000
Quarters > 2 > cash Flow > cash From Financing
-2257000
Quarters > 2 > cash Flow > net Change In Cash
2358000
Quarters > 2 > ratios > PE
0.3712283170513896
Quarters > 2 > ratios > PB
-1.1088240850846292
Quarters > 2 > ratios > ROE
-15.245440704148653
Quarters > 2 > ratios > ROA
11.118585820925766
Quarters > 2 > ratios > FCF
4837000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.09873040496407577
Quarters > 2 > health Score
48
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
49834000
Quarters > 3 > income Statement > cost Of Revenue
14304000
Quarters > 3 > income Statement > gross Profit
35530000
Quarters > 3 > income Statement > operating Expenses
32763000
Quarters > 3 > income Statement > operating Income
2767000
Quarters > 3 > income Statement > interest Expense
3222000
Quarters > 3 > income Statement > pretax Income
-1220000
Quarters > 3 > income Statement > net Income
3703000
Quarters > 3 > income Statement > eps
0.09930260501867268
Quarters > 3 > income Statement > dividends Per Share
88000
Quarters > 3 > income Statement > shares Outstanding
37290059
Quarters > 3 > income Statement > income Tax Expense
-4703000
Quarters > 3 > income Statement > EBITDA
3140000
Quarters > 3 > income Statement > operating Margin
5.552434081149416
Quarters > 3 > income Statement > total Other Income Expense Net
-3987000
Quarters > 3 > balance Sheet > cash
39342000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
7702000
Quarters > 3 > balance Sheet > inventories
14845000
Quarters > 3 > balance Sheet > total Current Assets
68127000
Quarters > 3 > balance Sheet > property Plant Equipment
10219000
Quarters > 3 > balance Sheet > total Assets
122370000
Quarters > 3 > balance Sheet > payables
5813000
Quarters > 3 > balance Sheet > short Term Debt
6773000
Quarters > 3 > balance Sheet > long Term Debt
101199000
Quarters > 3 > balance Sheet > total Liabilities
224570000
Quarters > 3 > balance Sheet > equity
-105928000
Quarters > 3 > cash Flow > net Income
3483000
Quarters > 3 > cash Flow > depreciation
1138000
Quarters > 3 > cash Flow > change In Working Capital
8397000
Quarters > 3 > cash Flow > cash From Operations
12368000
Quarters > 3 > cash Flow > capital Expenditures
1080000
Quarters > 3 > cash Flow > cash From Investing
-1311000
Quarters > 3 > cash Flow > cash From Financing
-9934000
Quarters > 3 > cash Flow > net Change In Cash
1117000
Quarters > 3 > ratios > PE
0.09930260501867268
Quarters > 3 > ratios > PB
-0.9504867391058077
Quarters > 3 > ratios > ROE
-3.4957707121818595
Quarters > 3 > ratios > ROA
3.0260684808368064
Quarters > 3 > ratios > FCF
11288000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.2265120199060882
Quarters > 3 > health Score
52
Valuation > metrics > PE
3.3671
Valuation > metrics > PB
-1.362372213440365
Valuation > final Score
70
Valuation > verdict
66.3% Undervalued
Profitability > metrics > ROE
-11.254828112328353
Profitability > metrics > ROA
14.3339810584178
Profitability > metrics > Net Margin
0.17073984485778632
Profitability > final Score
56
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
3.0248810830589097
Risk > final Score
42
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.10802110346061
Liquidity > metrics > Quick Ratio
3.637396047572208
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
29
Prev Profitabilities > 1
60
Prev Profitabilities > 2
27
Prev Risks > 0
45
Prev Risks > 1
43
Prev Risks > 2
33
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:18:11.806Z
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AReviewing Jin Medical International (NASDAQ:ZJYL) and biote (NASDAQ:BTMD) Defense World
Read more →Can BTMD stock outperform in 2025 bull market - July 2025 Review & Stepwise Trade Signal Guides moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$4.512
Analyst Picks
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 45.06% of the total shares of biote Corp
1.
325 Capital LLC(14.3507%)
since
2025/06/30
2.
Bandera Partners LLC(7.206%)
since
2025/06/30
3.
BlackRock Inc(5.553%)
since
2025/06/30
4.
Vanguard Group Inc(4.4918%)
since
2025/06/30
5.
Dimensional Fund Advisors, Inc.(1.9487%)
since
2025/06/30
6.
Geode Capital Management, LLC(1.9459%)
since
2025/06/30
7.
State Street Corp(1.5759%)
since
2025/06/30
8.
Hillsdale Investment Management Inc.(1.3261%)
since
2025/06/30
9.
Northern Trust Corp(0.8882%)
since
2025/06/30
10.
GlobeFlex Capital, L.P.(0.8595%)
since
2025/06/30
11.
Jacobs Levy Equity Management, Inc.(0.7022%)
since
2025/06/30
12.
Morgan Stanley - Brokerage Accounts(0.6963%)
since
2025/06/30
13.
Los Angeles Capital Management LLC(0.6321%)
since
2025/06/30
14.
Renaissance Technologies Corp(0.5692%)
since
2025/06/30
15.
Millennium Management LLC(0.4149%)
since
2025/06/30
16.
Perritt Capital Management Inc.(0.4034%)
since
2025/06/30
17.
Rice Hall James & Associates, LLC(0.3839%)
since
2025/06/30
18.
Bridgeway Capital Management, LLC(0.382%)
since
2025/06/30
19.
Marshall Wace Asset Management Ltd(0.3753%)
since
2025/06/30
20.
AQR Capital Management LLC(0.3518%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.